Kathy Giusti, M.B.A. ’85, founder and CEO of the Multiple Myeloma Research Foundation (MMRF), will address this year's imminent graduates of Harvard Business School as Class Day speaker. She founded the MMRF in 1998 after being diagnosed with multiple myeloma. This spring, Time magazine named her one of the "100 most influential people" in the world. Multiple myeloma is a cancer of plasma cells—white blood cells that produce antibodies; it affects from one to four people per 100,000 and constitutes 1 percent of all cancers. Before starting MMRF, Giusti was an executive with pharmaceutical companies, and she has sought to encourage the development of drugs to treat the disease using a business model, rather than an academic model, of drug development. The MMRF is the world's top funder of myeloma research: it has raised more than $165 million to fund research.
Multiple myeloma research crusader Kathy Giusti to speak at HBS Class Day
The founder of the Multiple Myeloma Research Foundation will speak at Harvard Business School Class Day.
Kathy Giusti | Photograph courtesy of the Multiple Myeloma Research Foundation
You might also like
A new proposed structure, layoffs, and a five-day-a-week in-person work mandate will take effect by fall.
At informational town hall meetings, faculty and staff press administrators for details.
The Emmy-winning journalist was a mainstay of political coverage at NBC for two decades.
Most popular
Explore More From Current Issue
With a grade inflation vote and in the courts, the University argued that it’s taking steps to change.
Harvard scientists identify hundreds of genes under selective pressure.
For both American and international students, growing up is like learning a new language.